Companies

ProMIS Neurosciences Inc. (PMN) SEC filings

CIK 0001374339 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in Z4 · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023
Net income (USD)-39.7 M-13.2 M-18.1 M
Diluted EPS (USD/shares)-22.61-1.07-2.41

Latest filings

FiledFormDescriptionPeriod
2026-10-064OWNERSHIP DOCUMENT2026-10-05
2026-10-063OWNERSHIP DOCUMENT2026-10-05
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-13SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-138-K8-K items 2.02,9.012026-08-13
2026-08-1310-Q10-Q2026-06-30
2026-08-13SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-074OWNERSHIP DOCUMENT2026-08-05
2026-07-288-K8-K items 7.01,8.01,9.012026-07-28
2026-05-29S-8S-8
2026-05-224OWNERSHIP DOCUMENT2026-05-20
2026-05-224OWNERSHIP DOCUMENT2026-05-20
2026-05-224OWNERSHIP DOCUMENT2026-05-20
2026-05-224OWNERSHIP DOCUMENT2026-05-20
2026-05-224OWNERSHIP DOCUMENT2026-05-20
2026-05-224OWNERSHIP DOCUMENT2026-05-20
2026-05-224OWNERSHIP DOCUMENT2026-05-20
2026-05-224OWNERSHIP DOCUMENT2026-05-20
2026-05-224OWNERSHIP DOCUMENT2026-05-20
2026-05-208-K8-K items 5.02,5.07,9.012026-05-20
2026-05-15SCHEDULE 13GSCHEDULE 13G
2026-05-15SCHEDULE 13GSCHEDULE 13G
2026-05-1210-Q10-Q2026-03-31
2026-05-128-K8-K items 2.02,9.012026-05-12
2026-05-07SCHEDULE 13G/ASCHEDULE 13G/A

Forms on file (last 1,000): 4 80, 8-K 61, D 27, 3 23, SCHEDULE 13G/A 17, SUPPL 14, 10-Q 13, 424B3 12. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=PMN (0.002 USD), /gw/filings/filings?ticker=PMN&form=8-K, /gw/filings/facts?ticker=PMN&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange